Collapsing glomerulopathy is likely a major contributing factor for worse allograft survival in patients receiving kidney transplants from black donors.

allograft outcomes collapsing glomerulopathy kidney pathology kidney transplantation racial disparities

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2024
Historique:
received: 11 01 2024
accepted: 22 02 2024
medline: 29 3 2024
pubmed: 29 3 2024
entrez: 29 3 2024
Statut: epublish

Résumé

Although a few registry-based studies have shown associations between receiving kidney allografts from Black donors and shorter allograft survival, detailed, large, single-center studies accounting for common confounding factors are lacking. Furthermore, pathologic alterations underlying this potential disparity have not been systematically studied. We performed a retrospective clinical-pathological study of kidney transplant recipients who received kidney allografts from either Black (

Identifiants

pubmed: 38549873
doi: 10.3389/fmed.2024.1369225
pmc: PMC10972956
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1369225

Informations de copyright

Copyright © 2024 DiFranza, Daniel, Serban, Thomas, Santoriello, Ratner, D’Agati, Vasilescu, Husain and Batal.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Lanny T DiFranza (LT)

Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.

Emily Daniel (E)

Medicine, Nephrology, Columbia University Irving Medical Center, New York, NY, United States.

Geo Serban (G)

Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.

Steven M Thomas (SM)

Surgery, Columbia University Irving Medical Center, New York, NY, United States.

Dominick Santoriello (D)

Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.

Lloyd E Ratner (LE)

Surgery, Columbia University Irving Medical Center, New York, NY, United States.

Vivette D D'Agati (VD)

Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.

Elena-Rodica Vasilescu (ER)

Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.

Syed Ali Husain (SA)

Medicine, Nephrology, Columbia University Irving Medical Center, New York, NY, United States.

Ibrahim Batal (I)

Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, United States.

Classifications MeSH